Pharmaceutical Industry Market Reports

 

In our analytical reports, we cover a wide range of industries and markets in pharma & healthcare. We show you future prospects across a wide range of commercial areas:

  • Novel branded pharmaceuticals – therapeutic applications and drug classes
  • Biopharmaceuticals (biologics) and healthcare biotechnology, including drug delivery and other technologies
  • Generic drugs, the Pharma supply chain and over-the-counter (OTC) medicines
  • Outsourced services – clinical trials, Pharma manufacturing and other roles
  • Diagnostic tests and instruments
  • Medical devices – implants and other products.

You will find revenue forecasts in a Visiongain report. Our reports analyse and explain commercial prospects at overall world, submarket, national and product level, suiting the topics. That way, you assess opportunities and commercial potentials for healthcare industries and markets.

  • Access to present and predicted trends, harnessing years of analytical experience and knowledge
  • Data and discussions – including our 10-year revenue forecasts – for your research, analyses and decision making
  • Tables, charts and lists to benefit your reports, proposals and presentations.

Our studies give you analysis from primary and secondary research. You receive information found only in our work– quantitative and qualitative analyses with independent predictions. Many commercial opportunities exist; we show you where these are and explain their significance and potential from this decade onwards. You can rely on our reports to help you stay ahead.

If you are interested in receiving more information about our reports or have any query, please contact us through our online form. 

Latest Pharma news

Vsiongain Publishes Asthma & COPD Therapies Market Report 2020-2030

Increasing pollution in emerging economies has resulted in degradation of air quality which is one of the major reasons for increasing COPD and asthma prevalence amongst children and teenagers.

11 August 2020

READ

Visiongain Publishes Pharma Contract Manufacturing Market Report 2020-2030

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry.

10 August 2020

READ

Visiongain Publishes Biologics Market Report 2020-2030

Biosimilars will be changing the biologics market in the long term. But whether it does it for the better or the worse will depend on how the producers of biologics respond to their market presence.

06 August 2020

READ

Visiongain Publishes Biochips Market Report 2020-2030

Conceptually, it is clear for all stakeholders in the health care segment as well in the biotechnological sector the benefits are evident since it will improve the speed and accuracy of diagnostics or analysis.

05 August 2020

READ